New advances in the management of children with intestinal failure (Q37970665)

26 August 2017

title

New advances in the management of children with intestinal failure (English)

1 reference

26 August 2017

Johann Peterson

1 reference

26 August 2017

John A Kerner

series ordinal

1 reference

26 August 2017

publication date

21 December 2011

1 reference

Journal of Parenteral and Enteral Nutrition

26 August 2017

published in

1 reference

26 August 2017

1 reference

26 August 2017

issue

1 Suppl

1 reference

26 August 2017

page(s)

36S-42S

1 reference

Short bowel syndrome and intestinal failure: consensus definitions and overview

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Classification, epidemiology and aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Pediatric short-bowel syndrome: the cost of comprehensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Neonatal short bowel syndrome: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Assessment of Small Bowel Function in Critical Illness: Potential Role of Citrulline Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Plasma citrulline as marker of bowel adaptation in children with short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Relationship between serum citrulline levels and progression to parenteral nutrition independence in children with short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Glucagonoma syndrome demonstrating giant duodenal villi

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Relationship between biopsy-proven parenteralnutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

The use of Omegaven in treating parenteral nutrition-associated liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Fish oil prevents essential fatty acid deficiency and enhances growth: clinical and biochemical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Prevention of parenteral nutrition-associated liver disease: lipid minimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Efficacy of ethanol locks in reducing central venous catheter infections in pediatric patients with intestinal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

Clinical Experience in Managing Pediatric Patients with Ultra-short Bowel Syndrome using Omega-3 Fatty Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111422069

21 January 2018

Identifiers

DOI

10.1177/0148607111422069

1 reference

26 August 2017

1 reference